OPEN END TURBO PUT WARRANT - AMGEN | Delayed Deutsche Boerse AG 05:37:30 2024-07-11 am EDT | ||
| 0.45 EUR | -6.25% |
|
| Current month | -9.43% | ||
| 1 month | -15.79% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
| Date | Price | Change |
|---|---|---|
| 24-07-11 | 0.45 | -6.25% |
| 24-07-10 | 0.48 | -5.88% |
| 24-07-09 | 0.51 | -7.27% |
| 24-07-08 | 0.55 | +1.85% |
| 24-07-05 | 0.54 | +1.89% |
Delayed Quote Deutsche Boerse AG
Last update July 11, 2024 at 05:37 am EDT
More quotesStatic data
| Product type | Warrant Knock-Out senza Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | AMGEN INC. |
| Issuer | UBS |
| WKN | UK7HBG |
| ISIN | DE000UK7HBG6 |
| Date issued | 2022-11-03 |
| Strike | 372 $ |
| Maturity | Unlimited |
| Parity | 100 : 1 |
| Emission price | 1.18 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 1.52 € |
|---|---|
| Lowest since issue | 0.45 € |
| Spread | 0.04 € |
| Spread % | 8.16% |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
321.7
USD
Average target price
316.1
USD
Spread / Average Target
-1.72%
- Stock Market
- Certificates
- Certificat
